Australian Pharmacist

        Opting for a better approach. Proton pump inhibitors (PPIs) were developed in the 1980s. Omeprazole, the first to be marketed, is on the WHO Model...

Highest risk travellers need additional support from pharmacists, particularly those who are visiting friends and relatives.

Pharmacy needs a diverse set of strong leaders to guide it through the most pivotal point of change in the profession. Could it be you?

Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.

The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.

Barriers to medicine safety show a health system failing to properly support Australians with a disability, a new report from PSA reveals.